Company news

CANbridge Pharmaceuticals Inc. news in 2023

CANbridge Pharmaceuticals Inc.'s news releases, calls and decks from 2023, newest first.

View company

CANbridge Announces NDA Acceptance of CAN108 for Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis by China's National Medical Products Administration

October 18, 2023

CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme in China Reaches Full Enrollment

March 29, 2023

CANbridge Pharmaceuticals Announces CAN008 Phase 1/2 Glioblastoma Multiforme Abstract Accepted by the ESMO Sarcoma and Rare Cancers Congress

March 14, 2023

Decks in 2023